Millipore Sigma Vibrant Logo

AGX841 Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.

View Products on Sigmaaldrich.com
AGX841
1 mg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Fulfillment and delivery delayed Fulfillment and delivery delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberAGX841
      DescriptionRecombinant SARS-CoV-2 Nucleocapsid Protein（fragment）
      Alternate Names
      • Severe acute respiratory syndrome coronavirus 2
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      HS Code3504 00 90
      PresentationPurified recombinant protein in 0.01M PBS, pH7.4
      Quality LevelMQ100
      Applications
      ApplicationThis e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.
      Key Applications
      • ELISA
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostE. coli
      SpecificitySARS CoV2
      Purification Methodni-sepharose
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      AGX841 04061842443543

      Documentation

      Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment） SDS

      Title

      Safety Data Sheet (SDS) 

      Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment） Certificates of Analysis

      TitleLot Number
      Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3802602 3802602
      Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3842809 3842809
      Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3852787 3852787
      Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - 3671754 3671754
      Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - Q3471655 Q3471655